Literature DB >> 14645599

Expression of unmodified hepatitis C virus envelope glycoprotein-coding sequences leads to cryptic intron excision and cell surface expression of E1/E2 heterodimers comprising full-length and partially deleted E1.

Julie Dumonceaux1, Emmanuel G Cormier, Francis Kajumo, Gerald P Donovan, Jayanta Roy-Chowdhury, Ira J Fox, Jason P Gardner, Tatjana Dragic.   

Abstract

Hepatitis C virus (HCV) is a positive-strand RNA virus that replicates exclusively in the cytoplasm of infected cells. The viral envelope glycoproteins, E1 and E2, appear to be retained in the endoplasmic reticulum, where viral budding is thought to occur. Surprisingly, we found that the expression system used to generate HCV envelope glycoproteins influences their subcellular localization and processing. These findings have important implications for optimizing novel HCV fusion and entry assays as well as for budding and virus particle formation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14645599      PMCID: PMC296095          DOI: 10.1128/jvi.77.24.13418-13424.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

Review 1.  Hepatitis C virus infection.

Authors:  G M Lauer; B D Walker
Journal:  N Engl J Med       Date:  2001-07-05       Impact factor: 91.245

2.  The transmembrane domains of hepatitis C virus envelope glycoproteins E1 and E2 play a major role in heterodimerization.

Authors:  A Op De Beeck; R Montserret; S Duvet; L Cocquerel; R Cacan; B Barberot; M Le Maire; F Penin; J Dubuisson
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

3.  Coexpression of hepatitis C virus envelope proteins E1 and E2 in cis improves the stability of membrane insertion of E2.

Authors:  Laurence Cocquerel; Jean-Christophe Meunier; Anne Op de Beeck; Dorine Bonte; Czeslaw Wychowski; Jean Dubuisson
Journal:  J Gen Virol       Date:  2001-07       Impact factor: 3.891

4.  Adverse effects of MVA-T7 on the transport of Marburg virus glycoprotein.

Authors:  C Sänger; E Mühlberger; H D Klenk; S Becker
Journal:  J Virol Methods       Date:  2001-01       Impact factor: 2.014

5.  Hepatitis C virus structural proteins reside in the endoplasmic reticulum as well as in the intermediate compartment/cis-Golgi complex region of stably transfected cells.

Authors:  G Martire; A Viola; L Iodice; L V Lotti; R Gradini; S Bonatti
Journal:  Virology       Date:  2001-02-15       Impact factor: 3.616

6.  Characterization of pseudotype VSV possessing HCV envelope proteins.

Authors:  Y Matsuura; H Tani; K Suzuki; T Kimura-Someya; R Suzuki; H Aizaki; K Ishii; K Moriishi; C S Robison; M A Whitt; T Miyamura
Journal:  Virology       Date:  2001-08-01       Impact factor: 3.616

7.  The transmembrane domain of the hepatitis C virus E2 glycoprotein is required for correct folding of the E1 glycoprotein and native complex formation.

Authors:  J Patel; A H Patel; J McLauchlan
Journal:  Virology       Date:  2001-01-05       Impact factor: 3.616

8.  Post-translational folding of the influenza C virus glycoprotein HEF: defective processing in cells expressing the cloned gene.

Authors:  S Szepanski; M Veit; S Pleschka; H D Klenk; M F Schmidt; G Herrler
Journal:  J Gen Virol       Date:  1994-05       Impact factor: 3.891

9.  Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses.

Authors:  J Dubuisson; H H Hsu; R C Cheung; H B Greenberg; D G Russell; C M Rice
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

10.  Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses.

Authors:  R Ralston; K Thudium; K Berger; C Kuo; B Gervase; J Hall; M Selby; G Kuo; M Houghton; Q L Choo
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

View more
  6 in total

1.  Functional analysis of hepatitis C virus envelope proteins, using a cell-cell fusion assay.

Authors:  Mariko Kobayashi; Michael C Bennett; Theodore Bercot; Ila R Singh
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

2.  Characterization of infectious retroviral pseudotype particles bearing hepatitis C virus glycoproteins.

Authors:  Mike Flint; Carine Logvinoff; Charles M Rice; Jane A McKeating
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

3.  L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus.

Authors:  Emmanuel G Cormier; Robert J Durso; Fotini Tsamis; Lise Boussemart; Catherine Manix; William C Olson; Jason P Gardner; Tatjana Dragic
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-15       Impact factor: 11.205

4.  CD81 is an entry coreceptor for hepatitis C virus.

Authors:  Emmanuel G Cormier; Fay Tsamis; Francis Kajumo; Robert J Durso; Jason P Gardner; Tatjana Dragic
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-03       Impact factor: 11.205

5.  Characterization of the genome and structural proteins of hepatitis C virus resolved from infected human liver.

Authors:  Søren U Nielsen; Margaret F Bassendine; Alastair D Burt; Debra J Bevitt; Geoffrey L Toms
Journal:  J Gen Virol       Date:  2004-06       Impact factor: 3.891

6.  Functional expression and characterization of the envelope glycoprotein E1E2 heterodimer of hepatitis C virus.

Authors:  Longxing Cao; Bowen Yu; Dandan Kong; Qian Cong; Tao Yu; Zibo Chen; Zhenzheng Hu; Haishuang Chang; Jin Zhong; David Baker; Yongning He
Journal:  PLoS Pathog       Date:  2019-05-22       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.